News

Deal Announcements

Arcion Nets $8 Million Venture Capital Debt

Thursday, February 4, 2010 5:31:00 AM PDT | VentureDeal Staff
Baltimore, Maryland  --  Biotechnology company Arcion Therapeutics has secured $8 million in a new round of venture debt financing.

Arcion is developing targeted treatments for diabetic neuropathy, post-herpetic neuralgia and other forms of moderate and severe pain.

Investors in the debt financing round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1